263 related articles for article (PubMed ID: 30240328)
1. Longitudinal Trajectory and Characterization of Cancer-Related Cognitive Impairment in a Nationwide Cohort Study.
Janelsins MC; Heckler CE; Peppone LJ; Ahles TA; Mohile SG; Mustian KM; Palesh O; O'Mara AM; Minasian LM; Williams AM; Magnuson A; Geer J; Dakhil SR; Hopkins JO; Morrow GR
J Clin Oncol; 2018 Sep; 36(32):JCO2018786624. PubMed ID: 30240328
[TBL] [Abstract][Full Text] [Related]
2. Longitudinal Changes in Cognitive Function in a Nationwide Cohort Study of Patients With Lymphoma Treated With Chemotherapy.
Janelsins MC; Mohamed M; Peppone LJ; Magnuson A; Belcher EK; Melnik M; Dakhil S; Geer J; Kamen C; Minasian L; Reagan PM; Mohile SG; Morrow GR; Ahles TA; Heckler CE
J Natl Cancer Inst; 2022 Jan; 114(1):47-59. PubMed ID: 34255086
[TBL] [Abstract][Full Text] [Related]
3. Cognitive Complaints in Survivors of Breast Cancer After Chemotherapy Compared With Age-Matched Controls: An Analysis From a Nationwide, Multicenter, Prospective Longitudinal Study.
Janelsins MC; Heckler CE; Peppone LJ; Kamen C; Mustian KM; Mohile SG; Magnuson A; Kleckner IR; Guido JJ; Young KL; Conlin AK; Weiselberg LR; Mitchell JW; Ambrosone CA; Ahles TA; Morrow GR
J Clin Oncol; 2017 Feb; 35(5):506-514. PubMed ID: 28029304
[TBL] [Abstract][Full Text] [Related]
4. Longitudinal Relationship Between Frailty and Cognition in Patients 50 Years and Older with Breast Cancer.
Magnuson A; Lei L; Gilmore N; Kleckner AS; Lin FV; Ferguson R; Hurria A; Wittink MN; Esparaz BT; Giguere JK; Misleh J; Bautista J; Mohile SG; Janelsins MC
J Am Geriatr Soc; 2019 May; 67(5):928-936. PubMed ID: 31034595
[TBL] [Abstract][Full Text] [Related]
5. Physical Activity Patterns and Relationships With Cognitive Function in Patients With Breast Cancer Before, During, and After Chemotherapy in a Prospective, Nationwide Study.
Salerno EA; Culakova E; Kleckner AS; Heckler CE; Lin PJ; Matthews CE; Conlin A; Weiselberg L; Mitchell J; Mustian KM; Janelsins MC
J Clin Oncol; 2021 Oct; 39(29):3283-3292. PubMed ID: 34406822
[TBL] [Abstract][Full Text] [Related]
6. Prechemotherapy Levels of Plasma Dehydroepiandrosterone and Its Sulfated Form as Predictors of Cancer-Related Cognitive Impairment in Patients with Breast Cancer Receiving Chemotherapy.
Toh YL; Shariq Mujtaba J; Bansal S; Yeo A; Shwe M; Lau AJ; Chan A
Pharmacotherapy; 2019 May; 39(5):553-563. PubMed ID: 30892712
[TBL] [Abstract][Full Text] [Related]
7. Fatigue, anxiety, and quality of life in breast cancer patients compared to non-cancer controls: a nationwide longitudinal analysis.
Williams AM; Khan CP; Heckler CE; Barton DL; Ontko M; Geer J; Kleckner AS; Dakhil S; Mitchell J; Mustian KM; Peppone LJ; Kipnis V; Kamen CS; O'Mara AM; Janelsins MC
Breast Cancer Res Treat; 2021 May; 187(1):275-285. PubMed ID: 33392843
[TBL] [Abstract][Full Text] [Related]
8. Relationship of systemic cytokine concentrations to cognitive function over two years in women with early stage breast cancer.
Lyon DE; Cohen R; Chen H; Kelly DL; McCain NL; Starkweather A; Ahn H; Sturgill J; Jackson-Cook CK
J Neuroimmunol; 2016 Dec; 301():74-82. PubMed ID: 27890459
[TBL] [Abstract][Full Text] [Related]
9. Effects of Acupuncture on Cancer-Related Cognitive Impairment in Chinese Gynecological Cancer Patients: A Pilot Cohort Study.
Zeng Y; Cheng ASK; Song T; Sheng X; Wang S; Xie J; Chan CCH
Integr Cancer Ther; 2018 Sep; 17(3):737-746. PubMed ID: 29806502
[TBL] [Abstract][Full Text] [Related]
10. Associations between inflammatory markers and cognitive function in breast cancer patients receiving chemotherapy.
Williams AM; Shah R; Shayne M; Huston AJ; Krebs M; Murray N; Thompson BD; Doyle K; Korotkin J; van Wijngaarden E; Hyland S; Moynihan JA; Cory-Slechta DA; Janelsins MC
J Neuroimmunol; 2018 Jan; 314():17-23. PubMed ID: 29128118
[TBL] [Abstract][Full Text] [Related]
11. Replication and Meta-analysis of the Association between BDNF Val66Met Polymorphism and Cognitive Impairment in Patients Receiving Chemotherapy.
Tan CJ; Lim SWT; Toh YL; Ng T; Yeo A; Shwe M; Foo KM; Chu P; Jain A; Koo SL; Dent RA; Ng RCH; Yap YS; Lim EH; Loh KW; Chay WY; Lee GE; Tan TJY; Beh SY; Wong M; Chan JJ; Khor CC; Ho HK; Chan A
Mol Neurobiol; 2019 Jul; 56(7):4741-4750. PubMed ID: 30382534
[TBL] [Abstract][Full Text] [Related]
12. Association of chemotherapy and subjective cognitive impairment in breast cancer patients: Meta-analysis of longitudinal prospective cohort studies.
Kim HJ; Jung SO; Kim E; Abraham I
Eur J Oncol Nurs; 2022 Apr; 57():102099. PubMed ID: 35255262
[TBL] [Abstract][Full Text] [Related]
13. An Evaluation of the Multifactorial Model of Cancer-Related Cognitive Impairment.
Oppegaard KR; Mayo SJ; Armstrong TS; Kober KM; Anguera JA; Wright F; Levine JD; Conley YP; Paul S; Cooper B; Miaskowski C
Nurs Res; 2023 Jul-Aug 01; 72(4):272-280. PubMed ID: 37104681
[TBL] [Abstract][Full Text] [Related]
14. Meta-analysis of cognitive functioning in breast cancer survivors previously treated with standard-dose chemotherapy.
Jim HS; Phillips KM; Chait S; Faul LA; Popa MA; Lee YH; Hussin MG; Jacobsen PB; Small BJ
J Clin Oncol; 2012 Oct; 30(29):3578-87. PubMed ID: 22927526
[TBL] [Abstract][Full Text] [Related]
15. Association of mitochondrial DNA content in peripheral blood with cancer-related fatigue and chemotherapy-related cognitive impairment in early-stage breast cancer patients: a prospective cohort study.
Chae JW; Chua PS; Ng T; Yeo AHL; Shwe M; Gan YX; Dorajoo S; Foo KM; Loh KW; Koo SL; Chay WY; Tan TJY; Beh SY; Lim EH; Lee GE; Dent R; Yap YS; Ng R; Ho HK; Chan A
Breast Cancer Res Treat; 2018 Apr; 168(3):713-721. PubMed ID: 29313215
[TBL] [Abstract][Full Text] [Related]
16. Associations of plasma brain-derived neurotrophic factor (BDNF) and Val66Met polymorphism (rs6265) with long-term cancer-related cognitive impairment in survivors of breast cancer.
Yap NY; Tan NYT; Tan CJ; Loh KW; Ng RCH; Ho HK; Chan A
Breast Cancer Res Treat; 2020 Oct; 183(3):683-696. PubMed ID: 32696315
[TBL] [Abstract][Full Text] [Related]
17. Predictors of baseline cancer-related cognitive impairment in cancer patients scheduled for a curative treatment.
Lycke M; Pottel L; Pottel H; Ketelaars L; Stellamans K; Van Eygen K; Vergauwe P; Werbrouck P; Goethals L; Schofield P; Boterberg T; Debruyne PR
Psychooncology; 2017 May; 26(5):632-639. PubMed ID: 27338029
[TBL] [Abstract][Full Text] [Related]
18. Protocol for the Exercise, Cancer and Cognition - The ECCO-Study: A Randomized Controlled Trial of Simultaneous Exercise During Neo-/Adjuvant Chemotherapy in Breast Cancer Patients and Its Effects on Neurocognition.
Kiesl D; Kuzdas-Sallaberger M; Fuchs D; Brunner S; Kommenda R; Tischler C; Hornich H; Akbari K; Kellermair J; Blessberger H; Ocenasek H; Hofmann P; Zimmer P; Vosko MR
Front Neurol; 2022; 13():777808. PubMed ID: 35401389
[TBL] [Abstract][Full Text] [Related]
19. Neuropsychological functioning among patients with different types of cancer : Postchemotherapy cognitive impairment and implications for rehabilitation.
Megari K
Neuropsychiatr; 2021 Jun; 35(2):92-97. PubMed ID: 32274652
[TBL] [Abstract][Full Text] [Related]
20. Relationship between cytokines and brain-derived neurotrophic factor (BDNF) in trajectories of cancer-related cognitive impairment.
Yap NY; Toh YL; Tan CJ; Acharya MM; Chan A
Cytokine; 2021 Aug; 144():155556. PubMed ID: 33985854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]